OneMedNet Financials
This page shows OneMedNet (ONMD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
OneMedNet has an operating margin of -1590.0%, meaning the company retains $-1590 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -1493.8% the prior year.
OneMedNet's revenue declined 5.4% year-over-year, from $643K to $608K. This contraction results in a growth score of 24/100.
OneMedNet's current ratio of 0.43 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 3/100, which could limit financial flexibility.
While OneMedNet generated -$7.5M in operating cash flow, capex of $13K consumed most of it, leaving -$7.5M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
OneMedNet passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, OneMedNet generates $2.68 in operating cash flow (-$7.5M OCF vs -$2.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
OneMedNet earns $-19.3 in operating income for every $1 of interest expense (-$9.7M vs $500K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
OneMedNet generated $608K in revenue in fiscal year 2025. This represents a decrease of 5.4% from the prior year.
OneMedNet's EBITDA was -$9.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 0.6% from the prior year.
OneMedNet reported -$2.8M in net income in fiscal year 2025. This represents an increase of 72.3% from the prior year.
OneMedNet earned $-0.06 per diluted share (EPS) in fiscal year 2025. This represents an increase of 83.3% from the prior year.
Cash & Balance Sheet
OneMedNet generated -$7.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 6.9% from the prior year.
OneMedNet held $585K in cash against $220K in long-term debt as of fiscal year 2025.
OneMedNet had 52M shares outstanding in fiscal year 2025. This represents an increase of 86.5% from the prior year.
Margins & Returns
OneMedNet's gross margin was -82.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 39.0 percentage points from the prior year.
OneMedNet's operating margin was -1590.0% in fiscal year 2025, reflecting core business profitability. This is down 96.2 percentage points from the prior year.
OneMedNet's net profit margin was -460.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1114.6 percentage points from the prior year.
Capital Allocation
OneMedNet invested $1.5M in research and development in fiscal year 2025. This represents an increase of 3.3% from the prior year.
OneMedNet invested $13K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 74.5% from the prior year.
ONMD Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $177K+14.2% | $155K+13.1% | $137K+426.9% | $26K-81.7% | $142K-37.4% | $227K-8.5% | $248K-23.0% | $322K |
| Cost of Revenue | $399K+0.8% | $396K+9.7% | $361K+594.2% | $52K-77.0% | $226K-31.3% | $329K+3.8% | $317K-6.2% | $338K |
| Gross Profit | -$222K+7.9% | -$241K-7.6% | -$224K-761.5% | -$26K+69.0% | -$84K+17.6% | -$102K-47.8% | -$69K-331.3% | -$16K |
| R&D Expenses | $323K-15.4% | $382K+9.8% | $348K+2.1% | $341K+14.4% | $298K-22.2% | $383K-13.9% | $445K-10.8% | $499K |
| SG&A Expenses | $1.4M+17.2% | $1.2M-13.1% | $1.4M-36.3% | $2.1M+17.9% | $1.8M+5.7% | $1.7M+26.4% | $1.4M+27.0% | $1.1M |
| Operating Income | -$2.2M-8.3% | -$2.1M+7.2% | -$2.2M+18.1% | -$2.7M-16.2% | -$2.3M+4.8% | -$2.5M-16.8% | -$2.1M-11.4% | -$1.9M |
| Interest Expense | $6K-72.7% | $22K-29.0% | $31K-66.7% | $93K+564.3% | $14K-6.7% | $15K-40.0% | $25K | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$192K |
| Net Income | -$741K-124.8% | $3.0M+256.8% | -$1.9M+19.8% | -$2.4M-15.3% | -$2.1M+42.7% | -$3.6M-70.2% | -$2.1M+15.5% | -$2.5M |
| EPS (Diluted) | $-0.01-114.3% | $0.07+216.7% | $-0.06 | N/A | $-0.07+50.0% | $-0.14-75.0% | $-0.08 | N/A |
ONMD Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.5M-35.6% | $2.3M+34.9% | $1.7M-53.5% | $3.7M-15.1% | $4.4M+321.5% | $1.0M+38.8% | $750K+61.6% | $464K |
| Current Assets | $1.4M-36.2% | $2.3M+39.0% | $1.6M-54.9% | $3.6M-15.9% | $4.3M+350.2% | $956K+45.7% | $656K+79.7% | $365K |
| Cash & Equivalents | $149K+22.1% | $122K-15.3% | $144K-16.3% | $172K-91.1% | $1.9M+375.2% | $407K+133.9% | $174K+270.2% | $47K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $582K+129.1% | $254K+2.8% | $247K+16.0% | $213K+238.1% | $63K-16.0% | $75K-70.4% | $253K+66.4% | $152K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.4M-11.9% | $6.2M-66.2% | $18.3M-7.1% | $19.7M+5.5% | $18.7M-7.8% | $20.2M+23.0% | $16.5M+18.3% | $13.9M |
| Current Liabilities | $5.0M-18.7% | $6.2M-66.1% | $18.2M-5.6% | $19.2M+3.2% | $18.6M-7.1% | $20.0M+36.8% | $14.7M+5.9% | $13.8M |
| Long-Term Debt | N/A | N/A | $2.3M+0.6% | $2.3M+0.6% | $2.3M-3.6% | $2.4M | N/A | $465K |
| Total Equity | -$3.9M-2.6% | -$3.8M+76.8% | -$16.6M-3.8% | -$15.9M-11.8% | -$14.3M+25.6% | -$19.2M-22.2% | -$15.7M-16.8% | -$13.4M |
| Retained Earnings | -$101.2M-0.7% | -$100.5M+2.9% | -$103.5M-1.9% | -$101.6M-2.4% | -$99.2M-2.1% | -$97.1M-3.8% | -$93.5M-2.3% | -$91.4M |
ONMD Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M+31.8% | -$2.3M-17.2% | -$1.9M+3.9% | -$2.0M-6.5% | -$1.9M-26.4% | -$1.5M+2.7% | -$1.5M+10.3% | -$1.7M |
| Capital Expenditures | $0-100.0% | $3K-40.0% | $5K-85.7% | $35K+288.9% | $9K+800.0% | $1K-83.3% | $6K-62.5% | $16K |
| Free Cash Flow | -$1.6M+31.9% | -$2.3M-17.1% | -$2.0M+5.3% | -$2.1M-7.8% | -$1.9M-26.9% | -$1.5M+3.0% | -$1.6M+10.8% | -$1.7M |
| Investing Cash Flow | $1.1M+265.4% | -$670K-134.9% | $1.9M+426.0% | $365K+115.6% | -$2.3M-233900.0% | -$1K+83.3% | -$6K+62.5% | -$16K |
| Financing Cash Flow | $477K | N/A | N/A | -$100K-101.8% | $5.5M+168.1% | $2.0M+21.4% | $1.7M+42.9% | $1.2M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ONMD Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -125.4%+30.1pp | -155.5%+8.0pp | -163.5%-63.5pp | -100.0%-40.8pp | -59.2%-14.2pp | -44.9%-17.1pp | -27.8%-22.9pp | -5.0% |
| Operating Margin | -1262.7%+68.3pp | -1331.0%+292.4pp | -1623.4%+8815.1pp | -10438.5%-8793.4pp | -1645.1%-564.0pp | -1081.1%-233.9pp | -847.2%-261.5pp | -585.7% |
| Net Margin | -418.6%-2342.5pp | 1923.9%+3312.2pp | -1388.3%+7738.6pp | -9126.9%-7677.6pp | -1449.3%+131.8pp | -1581.1%-730.7pp | -850.4%-75.2pp | -775.2% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -49.2%-176.8pp | 127.6%+237.4pp | -109.8%-46.2pp | -63.7%-16.8pp | -46.9%+297.9pp | -344.8%-63.6pp | -281.2%+256.7pp | -537.9% |
| Current Ratio | 0.29-0.1 | 0.37+0.3 | 0.09-0.1 | 0.19-0.0 | 0.23+0.2 | 0.050.0 | 0.04+0.0 | 0.03 |
| Debt-to-Equity | -1.38+0.2 | -1.61-1.5 | -0.140.0 | -0.15+0.0 | -0.16-0.0 | -0.12+0.9 | -1.05-1.0 | -0.03 |
| FCF Margin | -880.2%+595.2pp | -1475.5%-49.9pp | -1425.5%+6505.2pp | -7930.8%-6584.3pp | -1346.5%-682.6pp | -663.9%-37.7pp | -626.2%-85.5pp | -540.7% |
Note: Shareholder equity is negative (-$3.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.43), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is OneMedNet's annual revenue?
OneMedNet (ONMD) reported $608K in total revenue for fiscal year 2025. This represents a -5.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is OneMedNet's revenue growing?
OneMedNet (ONMD) revenue declined by 5.4% year-over-year, from $643K to $608K in fiscal year 2025.
Is OneMedNet profitable?
No, OneMedNet (ONMD) reported a net income of -$2.8M in fiscal year 2025, with a net profit margin of -460.7%.
What is OneMedNet's EBITDA?
OneMedNet (ONMD) had EBITDA of -$9.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does OneMedNet have?
As of fiscal year 2025, OneMedNet (ONMD) had $585K in cash and equivalents against $220K in long-term debt.
What is OneMedNet's gross margin?
OneMedNet (ONMD) had a gross margin of -82.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is OneMedNet's operating margin?
OneMedNet (ONMD) had an operating margin of -1590.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is OneMedNet's net profit margin?
OneMedNet (ONMD) had a net profit margin of -460.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is OneMedNet's free cash flow?
OneMedNet (ONMD) generated -$7.5M in free cash flow during fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is OneMedNet's operating cash flow?
OneMedNet (ONMD) generated -$7.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are OneMedNet's total assets?
OneMedNet (ONMD) had $2.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are OneMedNet's capital expenditures?
OneMedNet (ONMD) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does OneMedNet spend on research and development?
OneMedNet (ONMD) invested $1.5M in research and development during fiscal year 2025.
What is OneMedNet's current ratio?
OneMedNet (ONMD) had a current ratio of 0.43 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is OneMedNet's debt-to-equity ratio?
OneMedNet (ONMD) had a debt-to-equity ratio of -0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is OneMedNet's return on assets (ROA)?
OneMedNet (ONMD) had a return on assets of -130.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is OneMedNet's cash runway?
Based on fiscal year 2025 data, OneMedNet (ONMD) had $585K in cash against an annual operating cash burn of $7.5M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is OneMedNet's debt-to-equity ratio negative or unusual?
OneMedNet (ONMD) has negative shareholder equity of -$3.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is OneMedNet's Piotroski F-Score?
OneMedNet (ONMD) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are OneMedNet's earnings high quality?
OneMedNet (ONMD) has an earnings quality ratio of 2.68x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can OneMedNet cover its interest payments?
OneMedNet (ONMD) has an interest coverage ratio of -19.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is OneMedNet?
OneMedNet (ONMD) scores 7 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.